sotorasib
amgen
['sotorasib', 'pancreatic']
devalingam mahalingam, md, phd, of presents hcrn-gi21-499: a phase ib/ii study of sotorasib combined with chemotherapy for second line treatment of kras p. g12c mutated advanced pancreatic cancer during #asco2022 poster session. 
An independent nonprofit cancer research organization conducting multi-center investigator-initiated oncology studies since 1984.